From Liston Street Pulse:
Shares of Coronado Biosciences Inc. (CNDO), a biopharmaceutical company engaged in the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, have plunged in trading today after the company announced that its Phase 2 study evaluating TSO in 250 patients with moderate-to-severe Crohn's disease did […]
The post Coronado Biosciences Shares Plunge appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015